Oliver Lagore Vanvalin Investment Group’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$108K	Buy	+1,490	New	+$111K	0.04%	179
2024 Q4	$110K	Hold	1,490	–	–	0.03%	170
2024 Q3	$98.3K	Hold	1,490	–	–	0.03%	175
2024 Q2	$138K	Hold	1,490	–	–	0.04%	142
2024 Q1	$142K	Hold	1,490	–	–	0.04%	151
2023 Q4	$114K	Sell	1,490 -200	-12%	-$13.9K	0.04%	141
2023 Q3	$117K	Sell	1,690 -10	-0.6%	-$804	0.05%	155
2023 Q2	$160K	Hold	1,700	–	–	0.06%	143
2023 Q1	$141K	Hold	1,700	–	–	0.06%	107
2022 Q4	$127K	Sell	1,700 -82	-5%	-$6.32K	0.07%	111
2022 Q3	$147K	Buy	1,782 +18	+1%	+$1.73K	0.09%	97
2022 Q2	$168K	Buy	1,764 +64	+4%	+$6.63K	0.1%	98
2022 Q1	$200K	Buy	+1,700	New	+$191K	0.13%	95